Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Therrien

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifsStephen Hanessian, Daniel Simard, Malken Bayrakdarian, et al.
Journal of Chemical Information and Modeling|August 25, 2012
Development of a computational tool to rival experts in the prediction of sites of metabolism of xenobiotics by p450sValérie Campagna-Slater, Joshua Pottel, Eric Therrien, et al.
Journal of Chemical Information and Modeling|October 4, 2014
Docking ligands into flexible and solvated macromolecules. 7. Impact of protein flexibility and water molecules on docking-based virtual screening accuracyEric Therrien, Nathanael Weill, Anna Tomberg, et al.
Accounts of Chemical Research|August 17, 2016
Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design MethodsNicolas Moitessier, Joshua Pottel, Eric Therrien, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifsStephen Hanessian, Eric Therrien, Jianbin Zhang, et al.
Nature|April 5, 2019
An allosteric mechanism for potent inhibition of human ATP-citrate lyaseJia Wei, Silvana Leit, Jun Kuai, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structureStephen Hanessian, Eric Therrien, Willem A L van Otterlo, et al.
Journal of Chemical Information and Modeling|December 3, 2011
Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discoveryEric Therrien, Pablo Englebienne, Andrew G Arrowsmith, et al.
Journal of Medicinal Chemistry|July 7, 2012
Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cellsStéphane De Cesco, Sébastien Deslandes, Eric Therrien, et al.
Journal of Chemical Information and Modeling|June 2, 2023
A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, K<sub>p,uu</sub>Morgan Lawrenz, Mats Svensson, Mitsunori Kato, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifsStephen Hanessian, Daniel Simard, Malken Bayrakdarian, et al.
Journal of Chemical Information and Modeling|August 25, 2012
Development of a computational tool to rival experts in the prediction of sites of metabolism of xenobiotics by p450sValérie Campagna-Slater, Joshua Pottel, Eric Therrien, et al.
Journal of Chemical Information and Modeling|October 4, 2014
Docking ligands into flexible and solvated macromolecules. 7. Impact of protein flexibility and water molecules on docking-based virtual screening accuracyEric Therrien, Nathanael Weill, Anna Tomberg, et al.
Accounts of Chemical Research|August 17, 2016
Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design MethodsNicolas Moitessier, Joshua Pottel, Eric Therrien, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifsStephen Hanessian, Eric Therrien, Jianbin Zhang, et al.
Nature|April 5, 2019
An allosteric mechanism for potent inhibition of human ATP-citrate lyaseJia Wei, Silvana Leit, Jun Kuai, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structureStephen Hanessian, Eric Therrien, Willem A L van Otterlo, et al.
Journal of Chemical Information and Modeling|December 3, 2011
Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discoveryEric Therrien, Pablo Englebienne, Andrew G Arrowsmith, et al.
Journal of Medicinal Chemistry|July 7, 2012
Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cellsStéphane De Cesco, Sébastien Deslandes, Eric Therrien, et al.
Journal of Chemical Information and Modeling|June 2, 2023
A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, K<sub>p,uu</sub>Morgan Lawrenz, Mats Svensson, Mitsunori Kato, et al.
Pageof 3